Position in PFE
as of Jun 30, 2026
· filed Jul 14, 2026
Position Value
$797,072
-$134,903 QoQ
Shares Held
33,101
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.55%
of 13F equity value
Holder Rank
#1,458
of 2,821 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Murphy, Middleton, Hinkle & Parker, Inc. holds $15,661,585 across 8 Drug Manufacturers - General names. PFE ranks #5 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
25,918 | $6,582,394 | |
| 2 | LLY |
ELI LILLY & Co
|
3,750 | $4,497,862 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,472 | $1,345,652 | |
| 4 | AMGN |
Amgen Inc
|
3,661 | $1,325,721 | |
| 5 | PFE |
Pfizer Inc
This page
|
33,101 | $797,072 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
8,007 | $461,363 | |
| 7 | ABBV |
AbbVie Inc.
|
1,630 | $410,173 | |
| 8 | NVS |
Novartis AG
|
1,540 | $241,348 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $797,072 | 33,101 | Shares | Sole | 2026-07-14 | |
| 2026-03-31 | $931,975 | 33,190 | Shares | Sole | 2026-04-15 | |
| 2025-09-30 | $852,382 | 33,453 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $848,787 | 35,016 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $887,305 | 35,016 | Shares | Sole | 2025-04-15 | |
| 2024-12-31 | $999,066 | 37,658 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $1,134,997 | 39,219 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $1,122,865 | 40,131 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $1,136,390 | 40,951 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $1,213,843 | 42,162 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $1,572,722 | 47,414 | Shares | Sole | 2023-10-03 | |
| 2023-06-30 | $1,709,398 | 46,603 | Shares | Sole | 2023-07-05 | |
| 2023-03-31 | $1,961,215 | 48,069 | Shares | Sole | 2023-04-05 | |
| 2022-12-31 | $2,462,850 | 48,065 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $2,121,878 | 48,489 | Shares | Sole | 2022-10-07 | |
| 2022-06-30 | $2,479,362 | 47,289 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,410,825 | 46,568 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,801,981 | 47,451 | Shares | Sole | 2022-01-13 | |
| 2021-09-30 | $2,078,458 | 48,325 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,879,758 | 48,002 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $1,761,357 | 48,616 | Shares | Sole | 2021-04-08 | |
| 2020-12-31 | $1,823,677 | 49,543 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $1,821,786 | 49,640 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,700,761 | 52,011 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $1,665,584 | 51,029 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||